Mei Q, Li K, Tang T, Cai S, Liu Y, Wang X
Aging Cell. 2024; 23(11):e14293.
PMID: 39123275
PMC: 11561657.
DOI: 10.1111/acel.14293.
Bordan Z, Batori R, Haigh S, Li X, Meadows M, Brown Z
Circulation. 2024; 150(5):393-410.
PMID: 38682326
PMC: 11650665.
DOI: 10.1161/CIRCULATIONAHA.123.067095.
Chinyama H, Wei L, Mokgautsi N, Lawal B, Wu A, Huang H
Int J Mol Sci. 2023; 24(22).
PMID: 38003585
PMC: 10671581.
DOI: 10.3390/ijms242216396.
Xiao Y, Chen Y, Chen J, Dong J
Cancers (Basel). 2023; 15(22).
PMID: 38001686
PMC: 10670399.
DOI: 10.3390/cancers15225424.
Wang Q, Bode A, Zhang T
NPJ Precis Oncol. 2023; 7(1):58.
PMID: 37311884
PMC: 10264400.
DOI: 10.1038/s41698-023-00407-7.
PIN1 and CDK1 cooperatively govern pVHL stability and suppressive functions.
Chen J, Li M, Liu Y, Guan T, Yang X, Wen Y
Cell Death Differ. 2023; 30(4):1082-1095.
PMID: 36813923
PMC: 10070344.
DOI: 10.1038/s41418-023-01128-x.
and its correlated-myogenesis/cell cycle genes are prognosis-related markers of metastatic melanoma.
Bakr M, Takahashi H, Kikuchi Y
Biochem Biophys Rep. 2023; 33:101425.
PMID: 36654921
PMC: 9841360.
DOI: 10.1016/j.bbrep.2023.101425.
Role of ferroptosis-related genes in coronary atherosclerosis and identification of key genes: integration of bioinformatics analysis and experimental validation.
Meng Q, Xu Y, Ling X, Liu H, Ding S, Wu H
BMC Cardiovasc Disord. 2022; 22(1):339.
PMID: 35906548
PMC: 9338511.
DOI: 10.1186/s12872-022-02747-x.
MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer.
Zeng Y, Yin L, Zhou J, Zeng R, Xiao Y, Black A
Oncogene. 2022; 41(31):3859-3875.
PMID: 35780183
PMC: 9339507.
DOI: 10.1038/s41388-022-02399-3.
The phosphatase CTDSPL2 is phosphorylated in mitosis and a target for restraining tumor growth and motility in pancreatic cancer.
Xiao Y, Chen Y, Peng A, Dong J
Cancer Lett. 2021; 526:53-65.
PMID: 34813892
PMC: 8702485.
DOI: 10.1016/j.canlet.2021.11.018.
Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer.
Yin L, Zeng Y, Zeng R, Chen Y, Wang T, Rodabaugh K
Oncogene. 2021; 40(50):6772-6785.
PMID: 34799660
PMC: 8688329.
DOI: 10.1038/s41388-021-02117-5.
Development of a Multi-Target Strategy for the Treatment of Vitiligo via Machine Learning and Network Analysis Methods.
Wang J, Luo L, Ding Q, Wu Z, Peng Y, Li J
Front Pharmacol. 2021; 12:754175.
PMID: 34603063
PMC: 8479195.
DOI: 10.3389/fphar.2021.754175.
Replacement of Nitrite in Meat Products by Natural Bioactive Compounds Results in Reduced Exposure to N-Nitroso Compounds: The PHYTOME Project.
Van Breda S, Mathijs K, Pieters H, Sagi-Kiss V, Kuhnle G, Georgiadis P
Mol Nutr Food Res. 2021; 65(20):e2001214.
PMID: 34382747
PMC: 8530897.
DOI: 10.1002/mnfr.202001214.
High Expression Levels of CDK1 and CDC20 in Patients With Lung Squamous Cell Carcinoma are Associated With Worse Prognosis.
Deng H, Hang Q, Shen D, Ying H, Zhang Y, Qian X
Front Mol Biosci. 2021; 8:653805.
PMID: 34307447
PMC: 8292837.
DOI: 10.3389/fmolb.2021.653805.
PDZ-Binding Kinase-Dependent Transcriptional Regulation of CCNB2 Promotes Tumorigenesis and Radio-Resistance in Glioblastoma.
Mao P, Bao G, Wang Y, Du C, Yu X, Guo X
Transl Oncol. 2019; 13(2):287-294.
PMID: 31874375
PMC: 6931196.
DOI: 10.1016/j.tranon.2019.09.011.
Cyclin-dependent kinase 1-mediated AMPK phosphorylation regulates chromosome alignment and mitotic progression.
Stauffer S, Zeng Y, Santos M, Zhou J, Chen Y, Dong J
J Cell Sci. 2019; 132(20).
PMID: 31519809
PMC: 6826014.
DOI: 10.1242/jcs.236000.
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials.
Lin A, Giuliano C, Palladino A, John K, Abramowicz C, Yuan M
Sci Transl Med. 2019; 11(509).
PMID: 31511426
PMC: 7717492.
DOI: 10.1126/scitranslmed.aaw8412.
Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC.
Kar A, Zhang Y, Yacob B, Saeed J, Tompkins K, Bagby S
Endocr Relat Cancer. 2019; 26(10):765-778.
PMID: 31325906
PMC: 6938568.
DOI: 10.1530/ERC-19-0262.
Cyclin-dependent kinase 1-mediated phosphorylation of SET at serine 7 is essential for its oncogenic activity.
Yin L, Zeng Y, Xiao Y, Chen Y, Shen H, Dong J
Cell Death Dis. 2019; 10(6):385.
PMID: 31097686
PMC: 6522553.
DOI: 10.1038/s41419-019-1621-2.
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics.
Herbert K, Ashton T, Prevo R, Pirovano G, Higgins G
Cell Death Dis. 2018; 9(11):1089.
PMID: 30356039
PMC: 6200809.
DOI: 10.1038/s41419-018-1131-7.